Cancer Immunotherapy Drug Discovery Outsourcing

Global Market Trajectory & Analytics

MCP21411

EXECUTIVE ENGAGEMENTS

POOL

782
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

156
Interactions with Platform & by Email

PARTICIPANTS

31
Unique # Participated

VALIDATIONS

13
Responses Validated*

COMPANIES

34
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

321

PAGES

385

EDITION

4

PRICE

USD 5600

CODE

MCP21411


COMPETITIVE METRICS

COMPANY

D S N T

% *

*Login to Participate & View Data Stacks
View 34 Companies...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Cancer Immunotherapy Drug Discovery Outsourcing estimated at US$879.3 Million in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at a CAGR of 12.2% over the analysis period 2020-2027. Monoclonal Antibodies, one of the segments analyzed in the report, is projected to record a 11.7% CAGR and reach US$746.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Immunomodulators segment is readjusted to a revised 13.1% CAGR for the next 7-year period.
The Cancer Immunotherapy Drug Discovery Outsourcing market in the U.S. is estimated at US$237.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$427.8 Million by the year 2027 trailing a CAGR of 15.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.6% and 10.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.
In the global Oncolytic Viral Therapies & Cancer Vaccines segment, USA, Canada, Japan, China and Europe will drive the 11.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$138.3 Million in the year 2020 will reach a projected size of US$296 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$290.8 Million by the year 2027, while Latin America will expand at a 13.8% CAGR through the analysis period.

SELECT PLAYERS

Aquila Biomedical; BPS Biosciences Inc.; Celentyx Ltd.; Covance, Inc.; Crown Bioscience Inc.; DiscoverX Corporation; Explicit Immuno-Oncology; Explicyte; Gen script Biotech Corporation; HD Biosciences Co. Ltd.; Horizon Discovery Group PLC; ImmunXperts SA; Molecular Imaging Inc. (MI Bioresearch Inc.); Personalis, Inc.; Promega Corporation; STC Biologics

SEGMENTS

» Drug Type (Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines, Other Drug Types) » Service Type (Target Identification & Validation, Lead Screening & Characterization, Cell-Based Assays) » Cancer Type (Lung, Breast, Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Monoclonal Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Immunomodulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Immunomodulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Immunomodulators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Oncolytic Viral Therapies & Cancer Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Oncolytic Viral Therapies & Cancer Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Oncolytic Viral Therapies & Cancer Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Drug Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Drug Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Drug Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Prostate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Prostate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Prostate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Melanoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Melanoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Melanoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Pancreatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Pancreatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pancreatic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Colorectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Colorectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Colorectal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Head & Neck by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Head & Neck by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Head & Neck by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Ovarian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Ovarian by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Ovarian by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Lung by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Breast by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Target Identification & Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Target Identification & Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Target Identification & Validation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Lead Screening & Characterization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Lead Screening & Characterization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Lead Screening & Characterization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Cell-Based Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Cell-Based Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cell-Based Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
China Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
China Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
France Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
France Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
SPAIN
Spain Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
RUSSIA
Russia Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
AUSTRALIA
Australia Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
INDIA
India Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
India Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
India Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
ARGENTINA
Argentina Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
BRAZIL
Brazil Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
MEXICO
Mexico Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
MIDDLE EAST
Middle East Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
IRAN
Iran Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
ISRAEL
Israel Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
UNITED ARAB EMIRATES
UAE Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
AFRICA
Africa Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Drug Type - Percentage Breakdown of Value Sales for Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines and Other Drug Types for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Cancer Type - Percentage Breakdown of Value Sales for Prostate, Melanoma, Pancreatic, Colorectal, Head & Neck, Ovarian, Lung and Breast for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Cancer Immunotherapy Drug Discovery Outsourcing by Service Type - Percentage Breakdown of Value Sales for Target Identification & Validation, Lead Screening & Characterization and Cell-Based Assays for the Years 2012, 2020 & 2027
Total Companies Profiled: 34

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com